C M Hull

Summary

Affiliation: University of Utah
Country: USA

Publications

  1. ncbi Elevation of IgA anti-epidermal transglutaminase antibodies in dermatitis herpetiformis
    C M Hull
    Department of Dermatology, University of Utah, Salt Lake City, UT 84132, USA
    Br J Dermatol 159:120-4. 2008
  2. ncbi Valacyclovir and topical clobetasol gel for the episodic treatment of herpes labialis: a patient-initiated, double-blind, placebo-controlled pilot trial
    C Hull
    Department of Dermatology, University of Utah, Salt Lake City, UT, USA
    J Eur Acad Dermatol Venereol 23:263-7. 2009
  3. ncbi Early treatment of cold sores with topical ME-609 decreases the frequency of ulcerative lesions: a randomized, double-blind, placebo-controlled, patient-initiated clinical trial
    Christopher M Hull
    Department of Dermatology, School of Medicine, University of Utah, Salt Lake City, Utah 84132 2409, USA
    J Am Acad Dermatol 64:696.e1-11. 2011
  4. ncbi The role of topical 5% acyclovir and 1% hydrocortisone cream (Xerese™) in the treatment of recurrent herpes simplex labialis
    Christopher M Hull
    Department of Dermatology, School of Medicine, University of Utah, Salt Lake City, UT 84132, USA
    Postgrad Med 122:1-6. 2010

Detail Information

Publications4

  1. ncbi Elevation of IgA anti-epidermal transglutaminase antibodies in dermatitis herpetiformis
    C M Hull
    Department of Dermatology, University of Utah, Salt Lake City, UT 84132, USA
    Br J Dermatol 159:120-4. 2008
    ..More recently, antibodies directed at epidermal transglutaminase (TG3) were identified in patients with DH, and this may be the dominant autoantigen in this disease...
  2. ncbi Valacyclovir and topical clobetasol gel for the episodic treatment of herpes labialis: a patient-initiated, double-blind, placebo-controlled pilot trial
    C Hull
    Department of Dermatology, University of Utah, Salt Lake City, UT, USA
    J Eur Acad Dermatol Venereol 23:263-7. 2009
    ..The dual role of immune responses (protection, pathology) is well recognized in other infectious diseases. The addition of corticosteroids to antimicrobial agents has been associated with improvement in some of these diseases...
  3. ncbi Early treatment of cold sores with topical ME-609 decreases the frequency of ulcerative lesions: a randomized, double-blind, placebo-controlled, patient-initiated clinical trial
    Christopher M Hull
    Department of Dermatology, School of Medicine, University of Utah, Salt Lake City, Utah 84132 2409, USA
    J Am Acad Dermatol 64:696.e1-11. 2011
    ..ME-609 (Xerese, Xerclear) is a combination of 5% acyclovir and 1% hydrocortisone developed for the topical treatment of HSL...
  4. ncbi The role of topical 5% acyclovir and 1% hydrocortisone cream (Xerese™) in the treatment of recurrent herpes simplex labialis
    Christopher M Hull
    Department of Dermatology, School of Medicine, University of Utah, Salt Lake City, UT 84132, USA
    Postgrad Med 122:1-6. 2010
    ....